Aflibercept Drug Market: Next-Generation Anti-VEGF Biosimilars and...

σε πρόσθεσε στο Health

2026-11-06 10:56:05 -

Aflibercept Drug Market: Next-Generation Anti-VEGF Biosimilars and High-Dose Formulations for Ophthalmic Centers

Surging global incidence of age-related macular degeneration, expanding diabetic retinopathy patient populations, and continuous biopharmaceutical refinements in anti-VEGF fusion proteins are driving rapid growth across the global Aflibercept Drug Market. Aflibercept active pharmaceutical ingredients and finished biopharmaceutical dosage forms—comprising intravitreal pre-filled syringes,...

0 Σχόλια 0 Μοιράστηκε 47 Views 0 Προεπισκόπηση